Description:
Nafamostat Mesylate is a synthetic serine protease inhibitor and an anticoagulant. It is a fast-acting proteolytic inhibitor and used during hemodialysis to prevent the proteolysis of fibrinogen into fibrin.
- Molecular Weight: 539.58
- Molecular Formula: C21H25N5O8S2
Purity: >98%
Canonical SMILES:
CS(=O)(=O)O.CS(=O)(=O)O.C1=CC(=CC=C1C(=O)OC2=CC3=C(C=C2)C=C(C=C3)C(=N)N)N=C(N)N
InChI:
InChI=1S/C19H17N5O2.2CH4O3S/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23;2*1-5(2,3)4/h1-10H,(H3,20,21)(H4,22,23,24);2*1H3,(H,2,3,4)
InChIKey: SRXKIZXIRHMPFW-UHFFFAOYSA-N
- Boiling Point: 637.2°Cat 760 mmHg
- Melting Point: 259-261°C
- Solubility: In vitro: 10 mM in DMSO
- Appearance: Solid powder
- Application: Anti-Inflammatory Agents, Non-Steroidal
- Storage: 4°C, sealed storage, away from moisture* In solvent : -80°C, 6 months-20°C, 1 month (sealed storage, away from moisture)
Synonyms:
6-Amidino-2-naphthyl 4-guanidinobenzoate dimethanesulfonate; Nafamostat mesylate; nafamostat mesilate; FUT-175; FUT 175; FUT175
More details are to be found on supplier website
